These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5166217)

  • 1. Drug interactions: effect of methylphenidate on the disposition of diphenylhydantoin in man.
    Mirkin BL; Wright F
    Neurology; 1971 Nov; 21(11):1123-8. PubMed ID: 5166217
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary excretion of diphenylhydantoin metabolites in newborn infants.
    Rane A
    J Pediatr; 1974 Oct; 85(4):543-5. PubMed ID: 4475101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of phenobarbital on the half-life of diphenylhydantoin in man.
    Kristensen M; Hansen JM; Skovsted L
    Acta Med Scand; 1969 Apr; 185(4):347-50. PubMed ID: 5806342
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum protein binding of diphenylhydantoin in man. I. Interaction with sodium valproate.
    Lecchini S; Gatti G; De Bernardi M; Caravaggi M; Frigo GM; Calzetti S; Visintini D
    Farmaco Prat; 1978 Feb; 33(2):80-2. PubMed ID: 344060
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of serum diphenylhydantoin during antiepileptic therapy].
    Müller-Stüler M
    Nervenarzt; 1976 Apr; 47(4):244-7. PubMed ID: 1272481
    [No Abstract]   [Full Text] [Related]  

  • 6. The excretion of 5,5-diphenylhydantoin in the semen of man and the rabbit comparison with plasma concentrations of the drug.
    Leger RM; Swanson BN; Gerber N
    Proc West Pharmacol Soc; 1977; 20():69-72. PubMed ID: 896862
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum protein binding of diphenylhydantoin in man. II. Interaction with sodium valproate in epileptic patients.
    Gatti G; Lecchini S; Frigo GM; Visintini D; Calzetti S; Lombardi M; Cattaino G
    Farmaco Prat; 1979 Jan; 34(1):46-8. PubMed ID: 378689
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of anticonvulsive treatment on drug elimination in man. Induction of liver hydroxylating enzyme system by diphenylhydantoin and carbamazepine].
    Petruch F; Schüppel RV
    Bibl Psychiatr; 1975; (151):76-81. PubMed ID: 1156351
    [No Abstract]   [Full Text] [Related]  

  • 9. Folic acid and the half-life of diphenylhydantoin in man.
    Andreasen PB; Hansen JM; Skovsted L; Siersbaek-Nielsen K
    Acta Neurol Scand; 1971; 47(1):117-9. PubMed ID: 5576217
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of phenytoin metabolism by other drugs used in epilepsy.
    Houghton GW; Richens A
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):210-6. PubMed ID: 240782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One daily dose of diphenylhydantoin (DPH) to patients with epilepsy.
    Strandjord RE; Johannessen SI
    Acta Neurol Scand Suppl; 1972; 51():499-500. PubMed ID: 4514392
    [No Abstract]   [Full Text] [Related]  

  • 12. Diphenylhydantoin in children. Pharmacology and efficacy.
    Borofsky LG; Louis S; Kutt H
    Neurology; 1973 Sep; 23(9):967-72. PubMed ID: 4737688
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasma diphenylhydantoin concentration in epileptic patients].
    Herishanu Y; Eylath U
    Harefuah; 1974 Sep; 87(6):251-3. PubMed ID: 4442797
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects.
    Buchthal F; Svensmark O
    Psychiatr Neurol Neurochir; 1971; 74(2):117-36. PubMed ID: 5004709
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diphenylhydantoin poisoning due to diphenylhydantoin-isoniazid interaction].
    Geering JM; Ruch W; Dettli L
    Schweiz Med Wochenschr; 1974 Aug; 104(35):1224-8. PubMed ID: 4445849
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspects of diphenylhydantoin metabolism.
    Eadie MJ; Tyrer JH; Hooper WD
    Proc Aust Assoc Neurol; 1970; 7():7-13. PubMed ID: 5514827
    [No Abstract]   [Full Text] [Related]  

  • 17. A method for shifting from oral to intramuscular diphenylhydantoin administration.
    Wilder BJ; Serrano EE; Ramsey E; Buchanan RA
    Clin Pharmacol Ther; 1974 Sep; 16(3):507-13. PubMed ID: 4411662
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic study of a patient with diphenylhydantoin toxicity.
    Atkinson AJ; Shaw JM
    Clin Pharmacol Ther; 1973; 14(4):521-8. PubMed ID: 4198768
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbamazepine-induced acceleration of diphenylhydantoin and warfarin metabolism in man.
    Hansen JM; Siersboek-Nielsen K; Skovsted L
    Clin Pharmacol Ther; 1971; 12(3):539-43. PubMed ID: 5567804
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylphenidate (ritalin) and other drugs for treatment of hyperactive children.
    Med Lett Drugs Ther; 1977 Jul; 19(13):53-5. PubMed ID: 865414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.